Journal of Clinical Oncology · 2006 · 193 citations · 32 references
MedicineHematologyOncologyCancer GeneticsCytogeneticsMolecular OncologyCancer CytogeneticsCancer GenomicsMutation AnalysisOncogene MutationsCytogenetic AberrationsCytogenetic Prognostic MarkersDna In Situ HybridizationFlow Cytometry ImmunophenotypingLeukemia CytogeneticsMutationPrognostic Expression SignaturesZap-70 Activation
PURPOSE: Immunoglobulin heavy chain variable-region (VH) gene mutation status and zeta-associated protein 70 (ZAP-70) expression are correlated in chronic lymphocytic leukemia (CLL), but their concordance is variable. The goal of this study was to elucidate additional factors potentially characterizing their discordance. PATIENTS AND METHODS: We evaluated ZAP-70 expression by flow cytometry, VH status by DNA sequencing, and genomic aberrations by fluorescence in situ hybridization in 148 CLL patients. The parameters were analyzed for their associations and their individual prognostic impact. RESULTS: ZAP-70 expression and VH mutation status were strongly associated in CLL without additional genetic high-risk-features as defined by the absence of 11q or 17p deletion and V3-21 usage (concordance 84%). In contrast, the proportion of discordant cases was significantly higher (39%), if such additional genetic high-risk features were present. Discordant cases with V3-21 usage were almost exclusively ZAP-70 positive and VH mutated (89%), whereas all but one of the discordant cases with high-risk aberrations were ZAP-70 negative and VH unmutated (92%). By multivariate regression analysis, two models were developed, which both include high-risk genomic aberrations and, alternatively, VH mutation status and V3-21 usage or ZAP-70 expression as independent outcome predictors. CONCLUSION: There were characteristic modes of discordance between ZAP-70 and VH mutation status depending on the presence or absence of additional genetic high-risk features such as 11q and 17p deletion or V3-21 usage. Although the biologic background for these findings is yet to be determined, these data have biologic and clinical implications regarding ZAP-70 as a pathogenic factor and outcome predictor, respectively.
32
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
Hartmut Döhner, Stephan Stilgenbauer, Axel Benner et al. · New England Journal of Medicine · 2000 · 3.3K citations
Life Sciences, Genetics, Oncology +17
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
Terry J. Hamblin, Zadie Davis, Anne Gardiner et al. · Blood · 1999 · 2.7K citations
Life Sciences, Genetics, Oncology +11
Clinical staging of chronic lymphocytic leukemia
KR Rai, A Sawitsky, Cronkite Ep et al. · Blood · 1975 · 2.7K citations
Medicine, Hematology, Oncology +13
Rajendra N. Damle, Tarun Wasil, Franco Fais et al. · Blood · 1999 · 2.6K citations
Medicine, Hematology, Oncology +12